Further, the treatment of CRC cells with rifampicin enhanced the expression of PXR, SP1, and MRP3, which suggests the role of PXR in inducing resistance to chemotherapeutic agents in CRC cells [121]. This evidence concerns the gene ABCC3 and colorectal carcinoma.